Lake Street Advisors Group’s Rein Therapeutics RNTX Stock Holding History

Lake Street Advisors Group’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-825	Closed	-$3K	–	364
2022 Q3	$3K	Sell	825 -100	-11%	-$422	﹤0.01%	345
2022 Q2	$5K	Hold	925	–	–	﹤0.01%	318
2022 Q1	$10K	Hold	925	–	–	﹤0.01%	309
2021 Q4	$10K	Hold	925	–	–	﹤0.01%	284
2021 Q3	$19K	Hold	925	–	–	﹤0.01%	199
2021 Q2	$20K	Buy	925 +250	+37%	+$6.24K	﹤0.01%	332
2021 Q1	$19K	Hold	675	–	–	﹤0.01%	328
2020 Q4	$14K	Buy	+675	New	+$16.9K	﹤0.01%	313

Other funds holding RNTX

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Lake Street Advisors Group's RNTX Position: Q4 2022 in Review

Lake Street Advisors Group sold out of Rein Therapeutics (RNTX) in Q4 2022, closing a stake of 825 shares — an estimated $3K sold.

Lake Street Advisors Group first reported a position in RNTX in Q4 2020 and held it in 8 quarters. The position peaked at $20K in Q2 2021. 19 funds tracked by Wall St. Rank hold RNTX as of Q4 2022.

Lake Street Advisors Group reported no remaining Rein Therapeutics position as of Q4 2022 after selling out during the quarter.
Lake Street Advisors Group sold 825 Rein Therapeutics shares in Q4 2022, an estimated $3K.
Lake Street Advisors Group first reported a position in Rein Therapeutics in Q4 2020 and held it in 8 quarters.
Lake Street Advisors Group's Rein Therapeutics position peaked at $20K in Q2 2021.
19 funds tracked by Wall St. Rank held Rein Therapeutics as of Q4 2022.

Based on Lake Street Advisors Group's 13F filing for Q4 2022, filed 14 Feb 2023.